Release Date: 05/07/19
Expiration Date: 05/07/20
This educational program is targeted to healthcare providers who specialize in the management of persons who use drugs (PWUD).
On completion of this enduring activity, the participants should be better able to:
- Discuss data on the incidence, prevalence and transmission of HCV in persons who use drugs (PWUD)
- Describe the detrimental effects of chronic HCV, including the extrahepatic manifestations, to emphasize the need for diagnosis and treatment in PWUD
- Discuss updates in screening mandates and treatment guidelines for HCV including the importance of harm reduction and prevention of reinfection.
- Propose that HCV elimination is possible now that many prior HCV treatment obstacles have been removed
This enduring activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest:
All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF) have no relationships to disclose.
Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
This enduring activity is supported by an educational grant from AbbVie and Gilead.
This event is not part of the official ASAM Annual Conference as planned by its Program Committee.